The meeting will give healthcare providers, patients, drugmakers, pharmacists, pharmacy benefit managers, wholesalers and insurers, a platform to discuss systemic causes of shortages and offer solutions or prevention ideas.
Several discussion points for the meeting have been identified, including:
- The effect of drug shortages on patients, healthcare providers and the supply chain
- How data could more accurately capture the effects of drug shortages
- What factors affect the likelihood, severity and duration of drug shortages?
- Drugmakers’ role in drug shortages
- How to avoid production slowdowns
- Would more money get to the root of the problem?
- What regulations can be implemented to limit drug shortages?
The agency planned the meeting in response to a request from Congress to find ways to resolve the shortages.
More articles on supply chain:
9 things to know about the hospital-owned generic drug company
The first self-fitting hearing aid, a blood compatibility test & more: 5 latest FDA approvals
Blood bank issues urgent call for donors in wake of Hurricane Michael
